Sivextro Evrópusambandið - íslenska - EMA (European Medicines Agency)

sivextro

merck sharp & dohme b.v. - tedizólíð fosfat - soft tissue infections; skin diseases, bacterial - antibacterials for systemic use, , other antibacterials - sivextro is indicated for the treatment of acute bacterial skin and skin structure infections (absssi) in adults and adolescents 12 years of age and older.

Diprospan Stungulyf, dreifa 5+2 mg/ml Ísland - íslenska - LYFJASTOFNUN (Icelandic Medicines Agency)

diprospan stungulyf, dreifa 5+2 mg/ml

n.v. organon* - betamethasonum dínatríumfosfat; betamethasonum díprópíónat - stungulyf, dreifa - 5+2 mg/ml

Marcain spinal Stungulyf, lausn 5 mg/ml Ísland - íslenska - LYFJASTOFNUN (Icelandic Medicines Agency)

marcain spinal stungulyf, lausn 5 mg/ml

aspen pharma trading limited - bupivacainum hýdróklóríð - stungulyf, lausn - 5 mg/ml

Marcain spinal tung Stungulyf, lausn 5 mg/ml Ísland - íslenska - LYFJASTOFNUN (Icelandic Medicines Agency)

marcain spinal tung stungulyf, lausn 5 mg/ml

aspen pharma trading limited - bupivacainum hýdróklóríð - stungulyf, lausn - 5 mg/ml

Noritren Tafla 10 mg Ísland - íslenska - LYFJASTOFNUN (Icelandic Medicines Agency)

noritren tafla 10 mg

h. lundbeck a/s* - nortriptylinum hýdróklóríð - tafla - 10 mg

Noritren Tafla 25 mg Ísland - íslenska - LYFJASTOFNUN (Icelandic Medicines Agency)

noritren tafla 25 mg

h. lundbeck a/s* - nortriptylinum hýdróklóríð - tafla - 25 mg

Noritren Tafla 50 mg Ísland - íslenska - LYFJASTOFNUN (Icelandic Medicines Agency)

noritren tafla 50 mg

h. lundbeck a/s* - nortriptylinum hýdróklóríð - tafla - 50 mg